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 Background Few studies have investigated the association between whole-grain intake and colorectal cancer. Because whole-
grain intake estimation might be prone to measurement errors, more objective measures (eg, biomarkers) could 
assist in investigating such associations.
 Methods The association between alkylresorcinols, biomarkers of whole-grain rye and wheat intake, and colorectal can-
cer incidence were investigated using prediagnostic plasma samples from colorectal cancer case patients and 
matched control subjects nested within the European Prospective Investigation into Cancer and Nutrition. We 
included 1372 incident colorectal cancer case patients and 1372 individual matched control subjects and calcu-
lated the incidence rate ratios (IRRs) for overall and anatomical subsites of colorectal cancer using conditional 
logistic regression adjusted for potential confounders. Regional differences (Scandinavia, the Mediterranean, 
Central Europe) were also explored.
 Results High plasma total alkylresorcinol concentration was associated with lower incidence of distal colon cancer; the 
adjusted incidence rate ratio of distal colon cancer for the highest vs lowest quartile of plasma total alkylresorcin-
ols was 0.48 (95% confidence interval [CI] = 0.28 to 0.83). An inverse association between plasma total alkylres-
orcinol concentrations and colon cancer was found for Scandinavian participants (IRR per doubling = 0.83; 95% 
CI = 0.70 to 0.98). However, plasma total alkylresorcinol concentrations were not associated with overall colorectal 
cancer, proximal colon cancer, or rectal cancer. Plasma alkylresorcinols concentrations were associated with colon 
and distal colon cancer only in Central Europe and Scandinavia (ie, areas where alkylresorcinol levels were higher).
 Conclusions High concentrations of plasma alkylresorcinols were associated with a lower incidence of distal colon cancer but 
not with overall colorectal cancer, proximal colon cancer, and rectal cancer.
  J Natl Cancer Inst;2014;106:1–9 
Colorectal cancer is the third most common type of cancer world-
wide (1). Dietary and lifestyle habits have been proposed to account 
for a large proportion of colorectal cancers (2). Recently, the 
Continuous Update Project of the World Cancer Research Fund/
American Institute for Cancer Research (WCRF/AICR) Expert 
Report upgraded the evidence for an inverse association between 
dietary fiber intake and colorectal cancer risk to “convincing” 
(3). In particular, evidence suggests that intake of cereal fibers is 
more strongly associated with decreased colorectal cancer risk (4). 
Dietary fiber, and especially cereal fiber, would be expected to also 
represent whole-grain intake (5). Few studies have investigated the 
role of whole grains as such in colorectal cancer prevention because 
most prospective cohort studies have poor or no information on 
dietary intake of whole grains (6).
Adequate exposure measurement is one of the greatest challenges 
in nutritional epidemiology, and most prospective studies use food 
frequency questionnaires (FFQs) for dietary assessment. However, 
FFQs and other dietary assessment methods are prone to exposure 
misclassification, which might lead to attenuation of the diet–dis-
ease relationship under study (7). Previous studies on dietary fiber 
and colorectal cancer have found that methodological differences, 
especially regarding exposure measurement, might account for null 
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findings in some studies (8). Whole-grain intake might be even more 
prone to measurement errors than other food products because con-
sumers may have difficulties in accurately identifying whole-grain 
products and the actual whole-grain content varies greatly among 
whole-grain products (5,9). Therefore, using biomarkers of whole-
grain intake could be one attractive option to overcome some of 
these problems. Alkylresorcinols (1,3-dehydroxy-5-alkylbenzene 
homologs) are phenolic lipids found exclusively in the bran part of 
wheat, rye, and, to a very minor extent, barley among commonly 
consumed foods (10). Low or trace content is found in refined 
products (11). Alkylresorcinols are not affected by food processing 
(12), are absorbed in the small intestine (13), and can be measured 
in blood plasma (14). Intervention studies have shown that plasma 
alkylresorcinol concentrations are highly affected by dietary intake 
of whole-grain wheat and rye (15). In observational studies, mod-
erate correlations (r = 0.25–0.57) have been found when compar-
ing the plasma level of alkylresorcinols with different dietary intake 
measures (6,16). Despite the apparent short half-life, the long-term 
reproducibility (time period of 0.1–4 years) was moderate to good 
in populations with frequent whole-grain intake (17,18). Five alky-
lresorcinol homologs are generally analyzed, and in human plasma 
the ratio of two of these (C17:0/C21:0) is typically less than 0.2 if 
the consumed whole-grain mostly consists of wheat and is greater if 
whole-grain rye is also consumed (15,19).
In this study, we examined the association between plasma total 
alkylresorcinol concentrations as well as the C17:0/C21:0 ratio as 
an indicator of whole-grain source (wheat or rye) consumed and 
risk of overall colorectal cancer and colorectal cancer anatomi-
cal subsites in a case–control study nested within the European 
Prospective Investigation into Cancer and Nutrition (EPIC).
Methods
Study Population and Data Collection
The EPIC study is a large, multicenter cohort study that includes 
more than half a million European participants. The cohort con-
sists of 23 centers in Denmark, France, Greece, Germany, Italy, the 
Netherlands, Norway, Spain, Sweden, and the United Kingdom. 
Most participants were recruited from the general population. In 
this study, only one of the two Swedish cohorts participating in 
EPIC is included (Umeå). At baseline (years 1993–1998), lifestyle 
questionnaires, FFQs, and anthropometric measurements were 
collected from the participants (20).
Biological samples, including plasma samples, were collected at 
baseline from 385 747 of the 519 978 EPIC cohort participants and 
stored in nitrogen vapor or liquid nitrogen at less than −150 °C for 
later use, with the exception of the Swedish samples, which were 
stored in −80 °C freezers (20).
This study was approved by the Ethical Review Board at the 
International Agency for Research on Cancer (IARC) and the ethi-
cal committees of the participating centers. All participants pro-
vided informed consent.
Follow-up for Cancer Incidence and Vital Status
Cancer incidence was identified through record linkage with 
population cancer registries in most centers (20). End of follow-
up ranged from December 2002 to June 2005. During follow-up, 
2391 cohort members were diagnosed with colorectal cancer, 1550 
of whom were randomly selected to be part of this study.
Case Ascertainment and Selection
Colorectal cancer case patients were identified in accordance with 
the 10th Revision of the International Statistical Classification of 
Diseases, Injury and Causes of Death and the Second Edition of 
the International Classification of Diseases for Oncology. Proximal 
colon cancers were located in appendix, cecum, ascending colon, 
hepatic flexure, transverse colon, and splenic flexure (C18:0–
C18:5). Distal colon cancer included descending (C18:6) and sig-
moid colon cancers (C18:7). Overlapping (C18:8) and unspecified 
lesions (C18:9) of the colon were grouped among all colon cancers 
only (C18:0–C18:9). Cancers of the rectosigmoid junction (C19:9) 
and cancers of the rectum (C20) were grouped as rectal cancer.
Matching
The 1550 cohort participants who were diagnosed with colorectal 
cancer during the follow-up period were matched 1:1 with control 
subjects using incidence density sampling from eligible cohort mem-
bers who were alive and free of cancer at the time of the case patient’s 
diagnosis. Case patients were matched individually to control sub-
jects by sex, study center, age at blood collection (±5 years), date of 
blood collection (±6 months), time of blood collection (±4 hours), 
and fasting status (no: <3 hours, in-between: 3–6 hours, yes: >6 
hours). Women were further matched by menopausal status, phase of 
menstrual cycle, and use of oral contraceptives or hormone replace-
ment therapy at time of blood collection. The case–control set was 
also used for other studies, and for that reason not all matching fac-
tors are relevant for this study (such as phase of menstrual cycle).
Laboratory Analyses
Plasma alkylresorcinol homologs (C17:0, C19:0, C21:0, C23:0, 
C25:0) concentrations were determined by a gas chromatography–
mass spectrometry method in which molecular ions were used for 
quantification in single ion monitoring mode (21). Matched case–
control pairs were analyzed in the same batch, and quality control 
samples were included in each batch. The within- and between-
day precisions, expressed as coefficients of variation, were 11% and 
22%, respectively. Total plasma concentration (sum of homologs 
C17:0, C19:0, C21:0, C23:0, and C25:0) was used in the statistical 
analyses. Alkylresorcinols were successfully analyzed in only 2849 
samples of the initial 3100 samples, mostly because of missing sam-
ples or insufficient volume rather than laboratory errors.
Exclusions
Of the 2849 available samples, 34 colorectal cancer case patients 
were excluded because they had noncarcinomas and therefore had 
different pathology and possibly etiology. Furthermore, 71 par-
ticipants were excluded because they or their matched case patient 
or control subject had missing data on covariables. In total, 1372 
complete case–control sets (n  =  2744 participants in total) were 
included in the statistical analyses.
Statistical Analyses
Conditional logistic regression stratified by case–control pair was 
used to estimate odds ratios and 95% confidence intervals (CIs) of 
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colorectal cancer and anatomical subsites of colorectal cancer in 
relation to total alkylresorcinol concentration. Because of the inci-
dence density sampling method used, the estimated odds ratios are 
approximately the same as incidence rate ratios (IRRs) (22). Risk 
estimates are therefore presented as incidence rate ratios.
In the conditional logistic regression models, plasma total alky-
lresorcinol concentration was log2 transformed, meaning that the 
continuous risk estimates were expressed for doublings of plasma 
alkylresorcinol concentration (nmol/L). The associations were fur-
ther expressed as sex-specific quartiles based on the plasma total 
alkylresorcinol concentration among the control subjects.
Three conditional logistic regression models were constructed. 
The first was only conditioned on matching factors. The sec-
ond model was also conditioned on matching factors and further 
adjusted for potential confounders. A  third model was further 
adjusted for dietary folate intake because it has been questioned 
whether observed associations between fiber (and thereby possi-
bly whole grains) and the risk of colorectal cancer are confounded 
by folate intake (23,24). This could potentially be a problem in 
European observational studies because folic acid fortification is 
not mandatory and thus not widespread in Europe (23,24). All fac-
tors classified as “convincing” or “probable” risk factors of colo-
rectal cancer according to the report by the Continuous Update 
Project of the WCRF/AICR (3) were also investigated as potential 
confounders. Furthermore, factors previously identified as being 
associated with whole-grain intake (eg, intake of fruits, vegetables, 
and dairy products) were also evaluated (25). Because no other fac-
tors than those that are established risk factors for colorectal can-
cer affected the results (10% rule) (26), only the following were 
included in the adjusted model: body mass index (kg/m2, contin-
uous), smoking status (current, former, never), intake of red and 
processed meat (any intake, yes/no; g/day, continuous), education 
(none, primary school, technical/professional school, secondary 
school, longer education including university, not specified/miss-
ing), and physical activity according to the Total Physical Activity 
Index (inactive, moderately inactive, moderately active, active) (27), 
alcohol intake (abstainer, yes/no; g/day, continuous). The linear-
ity of the associations was evaluated graphically by linear splines 
with three boundaries placed at quartiles among case patients. No 
departures from linearity were found.
Competing risk tests were performed to investigate whether 
colon and rectum cancer and distal and proximal colon cancer 
could be merged (28). Tests for heterogeneity by region, fasting 
status, and sex were performed using Wald’s test. The regions were 
defined as follows: Scandinavia (Norway, Sweden, and Denmark), 
Central Europe (the United Kingdom, the Netherlands, and 
Germany), and the Mediterranean (France, Italy, Greece, and 
Spain). Effect modification by body mass index, meat intake, smok-
ing status, and physical activity level were also investigated, and 
testing deviation from interaction was done by introducing a prod-
uct term between exposure and potential effect modifiers.
Exclusion of case–control sets in which the case patients were 
diagnosed within the first year or within the first 2 years after base-
line did not change the results (results not shown).
To investigate whether whole-grain wheat or rye were differ-
entially associated with site-specific colorectal cancer, we calcu-
lated the ratio of alkylresorcinol homologs C17:0 and C21:0 and 
included this as a continuous predictor in the conditional logistic 
regression model. Two hierarchical models were estimated to test 
the linearity of C17:0/C21:0. More specifically, we fitted a model 
with the ratio C17:0/C21:0 as a linear term, then a model with 
the ratio C17:0/C21:0 as an orthogonal polynomial of order three. 
Model reduction was tested by means of likelihood ratio tests, and 
no difference was found (P > .05). The model was conditioned 
on matching factors and adjusted for plasma total alkylresorcinol 
concentration.
Correlations between plasma total alkylresorcinol concentra-
tions (geometric mean) and intake of cereal fiber estimated from 
FFQs were investigated using Pearson correlations.
All statistical tests were two-sided. A P value of less than .05 was 
considered statistically significant.
The statistical analyses were performed using SAS software 
version 9.3 (SAS Institute, Cary, NC) and using R (R Foundation 
for Statistical Computing, Vienna, Austria). In SAS, the univariate 
and freq procedures were used for the descriptive statistics, and the 
phreg procedure was used for the conditional logistic regression 
models.
results
Characteristics of Study Subjects
Colorectal cancer case patients (n  =  1372) and their individual 
matched control subjects (n  =  1372) were evenly distributed on 
matching factors as part of the study design (eg, sex, age, fasting 
status). Case patients were less likely to be physically active and 
had a higher energy intake, a slightly higher alcohol intake, and 
a higher intake of cereal products (Table  1). Additionally, case 
patients had a lower intake of breakfast cereals and dietary folate 
and a slightly lower plasma total alkylresorcinol concentration. 
The median concentration of plasma total alkylresorcinols was 54 
(5–95th percentile = 14–269) nmol/L among the participants from 
Scandinavia, 53 (5–95th percentile = 12–329) nmol/L among the 
Central European participants, and 15 (5–95th percentile = 6–91) 
nmol/L among the Mediterranean participants. Plasma total alkyl-
resorcinols was moderately correlated with cereal fiber intake esti-
mated from FFQs (r = 0.33; P < .001).
Associations Between Total Alkylresorcinols and 
Colorectal Cancer and Anatomical Subsites of 
Colorectal Cancer
No association was found between total alkylresorcinols and inci-
dence of overall colorectal cancer, rectal cancer, colon cancer, and 
proximal colon cancer (Table 2). For distal colon cancer, however, 
an inverse association was observed. A doubling in the plasma alky-
lresorcinol concentration was associated with a 17% lower inci-
dence of distal colon cancer (adjusted IRR = 0.83; 95% CI = 0.73 
to 0.95). When comparing the highest quartile with the lowest 
quartile, a 52% lower incidence of distal colon cancer was found in 
the highest quartile (adjusted IRR = 0.48; 95% CI = 0.28 to 0.83). 
Further adjustment for dietary folate slightly attenuated the asso-
ciation, but it remained statistically significant (adjusted IRR, high-
est vs lowest quartile = 0.53; 95% CI = 0.30 to 0.93). Competing 
risk tests showed that it was acceptable to merge colon and rectal 
cancers and distal and proximal colon cancers (P ≥ .33).
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Heterogeneity: Region, Fasting Status, and Sex
Because alkylresorcinols are expected to be useful as biomarkers 
of whole-grain intake especially in populations in which whole-
grain wheat and rye are a staple part of the diet (14), heterogeneity 
by region in the association between plasma total alkylresorcin-
ols and colorectal cancer was also investigated (Figure 1). When 
investigating the association between plasma total alkylresor-
cinols and colorectal cancer and anatomical subsites by region, 
Table 1. Characteristics of 1372 colorectal cancer case patients and their 1372 matched control subjects*
Characteristic Case patients Matched control subjects
Men, No.† 714 714
Women, No.† 658 658
Total, No. 1372 1372
Colorectal cancer subtype
 Colorectal cancer 1372 —
 Rectal cancer 501 —
 Colon cancer 871 —
 Proximal colon cancer 367 —
 Distal colon cancer 427 —
 Other colon cancer 77 —
Age at blood collection, y, median (P5–P95)† 59 (46–70) 59 (46–71)
Fasting status, %†
 Not fasting, <3 h 47 47
 In-between, 3–6 h 22 22
 Fasting, >6 h 29 29
 Unknown 2 2
BMI, kg/m2, median (P5–P95) 26 (21–34) 26 (21–33)
Smoking status, %
 Never 41 42
 Former 34 33
 Current smoker 24 24
 Unknown 1 1
Highest education level, %
 None 5 5
 Primary school completed 36 37
 Technical/professional school 24 25
 Secondary school 15 13
 Longer education, including university 17 18
 Unknown 3 2
Physical activity index, %
 Inactive 15 12
 Moderately inactive 28 26
 Moderately active 40 43
 Active 9 11
 Unknown 8 8
Energy intake, Kcal/d, median (P5–P95) 2070 (1169–3285) 2025 (1259–3290)
Alcohol abstainers, % 12 12
Alcohol, g/d, median (P5–P95)‡ 11 (0–64) 10 (0–60)
Red meat, g/d, median (P5–P95) 47 (5–125) 45 (5–120)
Processed meat, g/d, median (P5–P95) 25 (1–93) 24 (2–88)
Cereal and cereal products, g/d, median (P5–P95) 195 (76–426) 191 (77–423)
 Breakfast cereals, g/d, median (P5–P95) 0 (0–73) 0 (0–107)
 Bread and crisp bread, g/d, median (P5–P95) 119 (34–282) 120 (32–291)
 Bread, nonwhite, g/d, median (P5–P95) 63 (0–210) 63 (0–213)
Dietary fiber, g/d, median (P5–P95) 22 (12–36) 23 (12–37)
Cereal fiber, g/d, median (P5–P95) 8 (3–19) 8 (3–19)
Folate, µg/d, median (P5–P95) 285 (161–495) 291 (162–494)
Alkylresorcinols, nmol/L, median (P5–P95)
 Total, median (P5–P95) 38 (6–239) 39 (8–271)
 C17, median (P5–P95) 3 (0–18) 3 (0–19)
 C19, median (P5–P95) 8 (1–64) 9 (1–74)
 C21, median (P5–P95) 13 (3–97) 13 (3–102)
 C23, median (P5–P95) 6 (1–33) 6 (1–36)
 C25, median (P5–P95) 6 (1–40) 6 (1–44)
* BMI = body mass index; P5 = 5th percentile; P95 = 95th percentile.
† Matching factor.
‡ Among users only.
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the inverse association for distal colon cancer was present for 
Scandinavia and Central Europe (Central Europe: adjusted IRR, 
per doubling = 0.81, 95% CI = 0.67 to 0.99; Scandinavia: adjusted 
IRR, per doubling = 0.68, 95% CI = 0.53 to 0.88) but not for the 
Mediterranean (adjusted IRR, per doubling = 1.04, 95% CI = 0.80 
to 1.36). Furthermore, a statistically significant association was also 
found for overall colon cancer for Scandinavia (adjusted IRR, per 
doubling = 0.83; 95% CI = 0.70 to 0.98).
When testing for heterogeneity, no statistically significant dif-
ference was found between the three regions for either overall 
colorectal cancer or distal colon cancer (results not shown). When 
testing for heterogeneity between Scandinavia and Central Europe 
together vs the Mediterranean, a difference was found for distal 
cancer (P = .04) but not for overall colorectal cancer (P = .25). No 
heterogeneity was found between categories of fasting status or sex; 
however, associations seemed slightly stronger for men (Women: 
IRR, conditioned on matching factors, distal colon  =  0.88, 95% 
CI = 0.74 to 1.04; Men: IRR, conditioned on matching factors, dis-
tal colon = 0.79, 95% CI = 0.65 to 0.95).
Whole-Grain Wheat- or Rye-Dominated Diet
The ratio between the alkylresorcinol homologs C17:0 and 
C21:0 (C17:0/C21:0) indicates whether the diet is dominated by 
whole-grain wheat or rye (Figure  2). The association between 
the ratio C17:0/C21:0 and distal colon cancer adjusted for total 
alkylresorcinol concentration indicated no signs of a stronger 
inverse association for either whole-grain wheat or rye.
Effect modification
No signs of effect modification by body mass index, smoking status, 
physical activity, or intake of red and processed meat were found 
(Supplementary Table 1, available online).
Discussion
In this prospective study, which included participants from 10 
European countries, plasma total alkylresorcinol concentrations 
were inversely associated with risk of distal colon cancer. In the 
Scandinavian part of the cohort, plasma total alkylresorcinol con-
centrations were also inversely associated with colon cancer. No 
associations with other anatomical subsites of colorectal cancer 
(rectum and proximal colon) were seen. No difference in the asso-
ciation with distal colon cancer was found depending on the ratio 
of alkylresorcinol homologs C17:0 and C21:0, indicating that there 
were no differences depending on whether whole-grain wheat or 
whole-grain rye was chiefly consumed.
Heterogeneity by geographical region was observed when com-
paring associations for Scandinavia and Central Europe with the 
Mediterranean. The inverse association with distal colon cancer 
was only observed for Scandinavia and Central Europe, which 
IRR(95%CI)No. of case patients/control subjectsSubsite
  Colorectal cancer                                                            1372/1372
    Scandinavia                                                                448/448
    Central Europe                                                             517/517
    The Mediterranean                                                          407/407
  Rectal cancer                                                                501/501
    Scandinavia                                                                196/196
    Central Europe                                                             183/183
    The Mediterranean                                                          122/122
  Colon cancer                                                                 871/871
    Scandinavia                                                                252/252
    Central Europe                                                             334/334
    The Mediterranean                                                          285/285
  Proximal colon cancer                                                        367/367
    Scandinavia                                                                98/98
    Central Europe                                                             164/164
    The Mediterranean                                                          105/105
  Distal colon cancer                                                          427/427
    Scandinavia                                                                139/139
    Central Europe                                                             145/145
    The Mediterranean                                                          143/143
 0.5  0.7  0.9  1.1  1.3  1.5
Figure 1. Forest plot of regional and pooled incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between 
doubling in plasma concentration of alkylresorcinols with incidence of overall colorectal cancer and anatomical subsites, including rectal 
cancer, colon cancer, proximal colon cancer, and distal colon cancer. Incidence rate ratios were conditioned on matching factors (age, 
sex, study center, time of day of blood collection, and fasting status; for women, also menopausal status, phase of menstrual cycle, 
and use of hormone replacement therapy or oral contraceptives) and further adjusted for body mass index, intake of red and processed 
meat, physical activity, smoking status, education, and alcohol intake. The squares indicate the point estimates of incidence rate ratio for 
all regions pooled, and the circles indicate the point estimates for incidence rate ratios by region (Scandinavia, Central Europe, and the 
Mediterranean). The lines indicate the 95% confidence intervals.
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might be a consequence of stable and high whole-grain intakes in 
these regions, as well as a wider intake range.
Our findings are suggestive of a protective effect of whole-grain 
intake on colon cancer development, especially of distal colon 
cancer. The association is especially strong for the fourth quar-
tile. Therefore it can be questioned whether the association is lin-
ear. However, the association is also statistically significant when 
assessed by doubling in concentrations, and linear splines also indi-
cated that the association is linear (data not shown).
The association between whole-grain intake and colorectal 
cancer has been investigated in some cohort studies, but few stud-
ies are available, and the results have been inconsistent (29–36). 
A  recent published meta-analysis reported an inverse association 
between whole-grain intake and incidence of colorectal cancer (4). 
A number of mechanisms have been suggested as being responsible 
for this inverse association, some of which include improved bowel 
emptying, preventive effects of the short-chain fatty acid butyrate 
produced by fermentation in the colon, possible antioxidative 
effects, and dilution and entrapment of carcinogenic substances 
(37).
The association between plasma alkylresorcinol concentrations 
and risk of colorectal cancer was strongest for cancers of the distal 
part of the colon. Accumulating evidence suggests that the etiolo-
gies of distal and proximal cancer are likely to be different (38,39). 
The most recent study on intake of dietary fiber and incidence risk 
of colorectal cancer in the entire EPIC cohort also found a statis-
tically significant inverse association with distal colon cancer risk 
only and no association with risk of proximal colon cancer in the 
uncalibrated analysis (40). When associating cereal fiber intake with 
colorectal cancer incidence in our study population, the same pat-
tern of an association with distal colon cancer was found. Whole-
grain cereals are rich in lignified and resistant fibers present in the 
bran part of the grains, which are not fermented in the proximal 
colon but reach the distal colon (41). Because the proximal colon 
and the distal colon have different embryologic origin and there 
are differences in the mucosa (39,42), it seems plausible that diet 
might have different effect on the proximal and the distal colon.
The study has several strengths. First, plasma concentrations of 
alkylresorcinols are an independent, novel, and valid biomarker of 
whole-grain intake (14), with modest to good long-term reproduci-
bility in cohorts with frequent and stable intakes (17,18). Moreover, 
the prospective design with prediagnostic blood samples and the 
low risk of selection bias because the case–control study is nested 
within a cohort are considerable strengths. Furthermore, infor-
mation on many potential confounders was available, and a large 
number of case patients for whom detailed information on tumor 
morphology, behavior, and location was available are included.
Our study is not without limitations. Plasma levels of alky-
lresorcinols are influenced by between-subject differences in 
metabolism, which would lead to an attenuation of the association 
under investigation (14). Because of the apparent short half-life of 
approximately 5 hours, alkylresorcinol concentrations fluctuate 
substantially over time unless frequent intake is evident, and this 
will further contribute to regression dilution bias. This problem 
C17:0/C21:0 Ratio
IR
R
0.0 0.2 0.4 0.6 0.8 1.0
0.
5
1.
0
1.
5
2.
0
Figure 2. Association between the ratio of the two alkylresorcinol homologs C17:0 and C21:0 and distal colon cancer. Model adjusted for plasma 
total alkylresorcinol concentration and conditioned on matching factors. In human plasma alkylresorcinol, the C17:0/C21:0 ratio is typically 0.1 
to 0.2 when the diet is dominated by whole-grain wheat and 0.6 to 0.8 when the diet is dominated by whole-grain rye. IRR = incidence rate ratio.
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is further accentuated when using nonfasting samples (43). In this 
study, both fasting and nonfasting samples were used, and the case 
patients were matched to control subjects by fasting status; how-
ever, similar associations were observed when fasting and nonfast-
ing participants were analyzed separately. A statistically significant 
inverse association was found for distal colon cancer and for overall 
colon cancer in Scandinavia. Alkylresorcinols are biomarkers only 
of whole-grain wheat and rye intake, meaning that dietary intakes 
of other whole-grain cereals such as oats cannot be assessed using 
this biomarker. The within-batch precision was acceptable and the 
between-batch precision was somewhat higher than found previ-
ously for this method (18,43). This is probably because three indi-
viduals analyzed the data in a large number of batches over a long 
time period. The practical implication is probably small because 
case–control pairs were analyzed within the same batch and because 
of overall high between-subject variation.
In summary we found that high plasma total alkylresorcinol 
concentrations, reflecting high whole-grain wheat and rye intake, 
were not associated with a lower incidence of overall colorectal can-
cer, proximal colon cancer, or rectal cancer. However, a statistical 
inverse association was found with distal colon cancer and further-
more with overall colon cancer for the Scandinavian participants. 
The association with distal colon cancer was only observed among 
participants from Central Europe and Scandinavia (ie, in popula-
tions in which whole-grain wheat and rye are consumed regularly).
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